HPGAIT: Characterization of Dynamic Stability in Normal Pressure Hydrocephalus and Parkinson's Disease

Sponsor
Henri Mondor University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05998473
Collaborator
(none)
150
1
7
21.4

Study Details

Study Description

Brief Summary

This study aims to characterize dynamic stability disorders in two conditions mainly affecting the elderly and with similar walking deficits: hydrocephalus at normal pressure and Parkinson's disease, to provide the most relevant monitoring criteria in usual care.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Dynamic stability measurement

Detailed Description

Walking disorders in normal pressure hydrocephalus are manifested by slowing and ataxic gait, similar to disorders in Parkinson's disease. No studies in the literature have focused on advanced measures of dynamic stability in hydrocephalus at normal pressure, compared to Parkinson's disease, on large samples. The Laboratory of Analysis and Restoration of Movement, located in a Neurorehabilitation Department, provides quantitative data on gait and in particular dynamic stability as part of additional assessments to help patients follow up. Since 2010, people with normal pressure hydrocephalus or Parkinson's disease regularly benefit from these assessments. Retrospective analysis of all these data would help to better characterize motor disorders in hydrocephalus at normal pressure, by discriminating them from those associated with Parkinson's disease. It would lead to the definition of relevant indices to be used for patient follow-up.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Characterization of Dynamic Stability in Normal Pressure Hydrocephalus and Parkinson's Disease
Actual Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Normal pressure hydrocephalus

Patients with a diagnosis of normal pressure hydrocephalus and who performed a gait analysis in laboratories

Diagnostic Test: Dynamic stability measurement
The subject is asked to walk 8 meters 3 times: at free speed, at fast speed, and with large steps.

Parkinson's disease

Patients with a diagnosis of Parkinson's disease and who performed a gait analysis in laboratories

Diagnostic Test: Dynamic stability measurement
The subject is asked to walk 8 meters 3 times: at free speed, at fast speed, and with large steps.

Outcome Measures

Primary Outcome Measures

  1. Coefficient of variation in step length [30 seconds]

    Coefficient of variation in step length during 8-meter comfortable walking test

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age >18 years

  • Patient who performed a walking test in the Laboratory Analysis and Restoration of Movement

  • Diagnosis of normal pressure hydrocephalus or Parkinson's disease

Exclusion Criteria:
  • Levodopa drugs administrated during a delay of 12 hours before walking test

  • Presence of an other neurologic disease or of any disease associated with motor disorders in lower limb.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Laboratoire Analyse et Restauration du Mouvement Créteil France

Sponsors and Collaborators

  • Henri Mondor University Hospital

Investigators

  • Principal Investigator: Emilie Hutin, Henri Mondor University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Emilie Hutin, Co-director of laboratory, Henri Mondor University Hospital
ClinicalTrials.gov Identifier:
NCT05998473
Other Study ID Numbers:
  • 2023-A01762-43
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023